These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2127937)

  • 1. Implantation and pregnancy rates in relation to oestradiol and progesterone profiles in cycles with and without the use of gonadotrophin-releasing hormone agonist suppression.
    Hassiakos D; Toner JP; Muasher SJ; Jones HW
    Hum Reprod; 1990 Nov; 5(8):1004-8. PubMed ID: 2127937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
    Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
    Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin.
    Harada T; Yoshida S; Katagiri C; Takao N; Ikenari T; Toda T; Mio Y; Terakawa N
    Hum Reprod; 1995 May; 10(5):1060-4. PubMed ID: 7657741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET.
    Gelety TJ; Surrey ES
    J Assist Reprod Genet; 1997 Oct; 14(9):525-30. PubMed ID: 9401871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of serum estradiol levels on the implantation rate of cleavage stage cryopreserved-thawed embryos transferred in programmed cycles with exogenous hormonal replacement.
    Bocca S; Real EB; Lynch S; Stadtmauer L; Beydoun H; Mayer J; Oehninger S
    J Assist Reprod Genet; 2015 Mar; 32(3):395-400. PubMed ID: 25563580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization.
    Brzyski RG; Jones GS; Jones HW; Oehninger S; Muasher SJ
    Fertil Steril; 1991 Jan; 55(1):119-24. PubMed ID: 1898886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.
    Yıldız GA; Şükür YE; Ateş C; Aytaç R
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():66-70. PubMed ID: 25238659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.
    Silverberg KM; Burns WN; Olive DL; Riehl RM; Schenken RS
    J Clin Endocrinol Metab; 1991 Oct; 73(4):797-803. PubMed ID: 1909704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin-releasing hormone agonist impairs follicular recruitment for in-vitro fertilization.
    Sims JA; Seltman HJ; Muasher SJ
    Hum Reprod; 1994 Feb; 9(2):235-40. PubMed ID: 8027278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial receptivities after leuprolide suppression and gonadotropin stimulation: histology, steroid receptor concentrations, and implantation rates.
    Toner JP; Hassiakos DK; Muasher SJ; Hsiu JG; Jones HW
    Ann N Y Acad Sci; 1991; 622():220-9. PubMed ID: 1905893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone response to exogenous gonadotropins after suppression with leuprolide acetate in gamete intrafallopian transfer.
    Riemann DC; Schoolcraft WB; Sinton EB
    J Reprod Med; 1991 Mar; 36(3):190-4. PubMed ID: 1903164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone.
    Testart J; Forman R; Belaisch-Allart J; Volante M; Hazout A; Strubb N; Frydman R
    Hum Reprod; 1989 Feb; 4(2):198-201. PubMed ID: 2521866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization.
    Padilla SL; Bayati J; Garcia JE
    Fertil Steril; 1990 Feb; 53(2):288-94. PubMed ID: 2105245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate.
    Schoolcraft W; Sinton E; Schlenker T; Huynh D; Hamilton F; Meldrum DR
    Fertil Steril; 1991 Mar; 55(3):563-6. PubMed ID: 1900481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone, progesterone/estradiol and ART outcomes in day-5 transfer cycles.
    Arora R; Chan C; Ye XY; Greenblatt EM
    Gynecol Endocrinol; 2018 Jan; 34(1):59-63. PubMed ID: 28670921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormone-binding globulin, oestradiol-17 beta, progesterone and testosterone at stimulation and after embryo transfer during in-vitro fertilization.
    Gustafson O; Lunell NO; Nylund L; Pousette A; Akerlöf E; Carlström K
    Hum Reprod; 1991 Sep; 6(8):1039-42. PubMed ID: 1806559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteal estrogen supplementation in pregnancies associated with low serum estradiol concentrations.
    Kaider AS; Coulam CB
    Early Pregnancy (Cherry Hill); 2000 Jul; 4(3):191-9. PubMed ID: 11727011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilization-embryo transfer success.
    Seifer DB; Thornton KL; DeCherney AH; Lavy G
    Fertil Steril; 1991 Sep; 56(3):500-4. PubMed ID: 1909977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.